AZ31/Mg‐Y/AZ31 composites are fabricated by hot rolling bonding. To identify the formation mechanism of the microstructure in the interface adjacent region, additional hot rolling or/and diffusion annealing are also conducted on the base of the initial AZ31/Mg‐Y/AZ31 composite. Scanning electron microscopy, energy dispersive spectroscopy, and electron backscatter diffraction are used to characterize the microstructures and chemical compositional distributions. Vicker's microhardness tests are conducted to determine the local mechanical property. It is found that in the Mg–Y layer of the AZ31/Mg‐Y/AZ31 composite, the grain size in the interface‐adjacent region is much finer than that in the central part. Much finer Al2Y particles compared with those in the traditional Mg–Al–Y alloys are formed in the interface‐adjacent region. The formation of the fine grain in the interface‐adjacent region may be mainly related to the Al2Y particles rather than the accommodation deformation between layers. Both the grain refinement and the formation of Al2Y particles contribute to strengthening of the Mg–Y layer. The results in this work may provide a novel method to prepare fine and dispersed high‐melting‐point particles in Mg alloys, thus leading to strong and high‐thermal‐stability Mg alloys.

No abstract

Background: Xiao-Ban-Xia-Tang (XBXT) formula is a traditional Chinese herbal formula for treating emesis. Chemotherapy-induced nausea and vomiting (CINV) are serious side effects of chemotherapy, which was closely related to the activation of 5-hydroxytryptamine 3 receptor (5-HT3R). In this paper, the effect of XBXT on cisplatin- and 1-phenylbiguanide hydrochloride (1-PBG, a selective 5-HT3R agonist)- induced pica behavior in male Wistar rats and inhibition of calmodulin/calmodulin-dependent protein kinase II/extracellular signal-regulated kinase 1/2 (CaM/CaMKII/ERK1/2) signaling pathway were investigated. Methods: XBXT (1.6 g/kg, twice daily) was orally administered from day 1 after intraperitoneal injection of cisplatin (6 mg/kg) and 1-PBG (25 mg/kg) to day 3. Pica behavior (consumption of kaolin, a type of clay) was recorded every 24 h. The expression and co-localization of CaM and 5-HT3R in small intestine and brain were detected by immunofluorescence. The expression of CaMKII, pCaMKII, ERK1/2, and pERK1/2 proteins were detected by Western blot. Results: XBXT treatment significantly decreased kaolin ingestion (pica) of rats after treatment of cisplatin and 1-PBG during both 0 - 24 h (respectively, from 1.57 g to 0.87 g; from 1.04 g to 0.11 g) and 0 - 72 h (respectively, from 2.98 g to 1.85 g; from 2.29 g to 0.35 g) periods. The fluorescence expression of CaM and 5-HT3R and expression of CaMKII, pCaMKII, ERK1/2 and pERK1/2 in the small intestine and brain of cisplatin- and 1-PBG-treated rats were remarkably suppressed by XBXT.Conclusions: The present study implies that inhibiting CaM/CaMKII/ERK1/2 signaling is an underlying mechanism of XBXT for treating CINV. These insights provide an experimental basis of XBXT for the clinical treatment of CINV.